Beta Bionics, Inc.
BBNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$55 | -$44 | -$65 |
| Dep. & Amort. | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $6 | $6 |
| Change in WC | -$12 | -$6 | -$3 |
| Other Non-Cash | $10 | $10 | -$1 |
| Operating Cash Flow | -$48 | -$32 | -$60 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$3 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$72 | $0 | $0 |
| Inv. Sales/Matur. | $72 | $0 | $0 |
| Other Inv. Act. | $0 | -$69 | $0 |
| Investing Cash Flow | -$3 | -$70 | -$1 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $56 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $101 | $57 |
| Financing Cash Flow | $56 | $101 | $57 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | -$1 | -$4 |
| Supplemental Information | – | – | – |
| Beg. Cash | $27 | $28 | $32 |
| End Cash | $31 | $27 | $28 |
| Free Cash Flow | -$52 | -$33 | -$61 |